This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.


By talk medicine

ESMO Open is the European Society for Medical Oncology’s online-only, peer-reviewed Open Access journal, dedicated to publishing high-quality medical research and educational content from all disciplines of oncology, with a focus on innovative clinical and translational cancer research. The journal is published by BMJ on behalf of ESMO. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

  1. 1.
    The ESMO-Magnitude of Clinical Benefit Scale Group09/09/2019
  2. 2.
    What is new on the horizon in Melanoma Brain Metastasis?08/09/2019
  3. 3.
    ESMO 2018 Presidential Symposium – IMpassion130: Atezolizumab in triple negative breast cancer10/04/2018
  4. 4.
    ESMO 2018 Presidential Symposium: radiotherapy to the primary tumor in metastatic prostate cancer10/03/2018
  5. 5.
    The Metastatic Breast Cancer project: a novel patient-partnered initiative09/05/2018
  6. 6.
    Biosimilars in oncology07/24/2018
  7. 7.
    Tumor evolution in non-small-cell lung cancer07/20/2018
  8. 8.
    Immune checkpoint inhibitors for every non-small cell lung cancer patient07/17/2018

Listen to ESMO Open now.

Listen to ESMO Open in full in the Spotify app